Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€38.37

€38.37

-1.160%
-0.45
-1.160%
€48.50
 
13:31 / Tradegate WKN: 578580 / Symbol: FMCQF / Name: Fresenius Medical Care / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Fresenius Medical Care AG & Co KGaA ST Stock

We can see a decrease in the price for Fresenius Medical Care AG & Co KGaA ST. Compared to yesterday it has lost -€0.450 (-1.160%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Fresenius Medical Care AG & Co KGaA ST.
With a target price of 48 € there is a positive potential of 25.1% for Fresenius Medical Care AG & Co KGaA ST compared to the current price of 38.37 €.
Our community identified positive and negative aspects for Fresenius Medical Care AG & Co KGaA ST stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Fresenius Medical Care AG & Co KGaA ST stock. On the other hand our users think that "General Risks" could be a problem in the future.

Fresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.

Pros and Cons of Fresenius Medical Care AG & Co KGaA ST in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Fresenius Medical Care AG & Co KGaA ST vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Fresenius Medical Care AG & Co KGaA ST -1.160% 9.291% 12.554% -8.097% 2.590% -40.350% -46.158%
Fresenius SE & Co. KGaA 0.740% 2.142% 9.951% 4.138% -3.788% -31.277% -46.189%
Fresenius SE & Co. KGaA ADR 0.740% 4.651% 12.500% 4.651% -3.571% -31.472% -46.850%
Quest Diagnostics Inc. 0.700% 8.067% 7.435% -2.686% 3.376% 18.635% 52.822%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15

Upon reviewing the financial statements of Fresenius Medical Care (US symbol FMCQF), a company operating in the Healthcare Providers & Services industry, it appears to have a stable financial performance with some positive growth indicators. However, there are certain aspects that require a closer examination and could pose potential concerns. In the following analysis, we will explore the company's strengths and weaknesses based on its financial reports for the past three years.

*Pros: *

*Cons: *

Comments

Sell Fresenius Medical Care AG & Co KGaA ST
Show more

Sell Fresenius Medical Care AG & Co KGaA ST
Show more

Buy Fresenius Medical Care AG & Co KGaA ST
Show more

News

EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23608/Fresenius_Medical_Care_20xx_logo.svg.png
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023
EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023